Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 1—January 2004

Correction

Correction Vol. 9, No. 6

Cite This Article

Close

Highlight and copy the desired format.

EID Correction Vol. 9, No. 6. Emerg Infect Dis. 2004;10(1):160. https://dx.doi.org/10.3201/eid1001.C11001
AMA Correction Vol. 9, No. 6. Emerging Infectious Diseases. 2004;10(1):160. doi:10.3201/eid1001.C11001.
APA (2004). Correction Vol. 9, No. 6. Emerging Infectious Diseases, 10(1), 160. https://dx.doi.org/10.3201/eid1001.C11001.

In "Clinical Implications of Varying Degrees of Vancomycin Susceptibility in Methicillin-Resistant Staphylococcus aureus Bactermia, by Mitchell J. Schwaber et al., errors occurred in some reference numbers. In the Discussion, fourth paragraph, p. 661, the last sentence should read as follows: 'It is possible that some or all of the isolates from our cases are potential precursors of truly heteroresistant isolates (hetero-VISA), which may in turn be forerunners of VISA (6,18,32)." In the final paragraph, pp. 662-663, the next to last sentence should read as follows:

"These results add weight to assertions that clinical microbiology laboratories need not routinely screen for vancomycin heteroresistance in S. aureus isolates with vancomycin MICs in the susceptible range (1,7).”

The corrected article can be found online at http://wwwnlc.cdc.gov/eid/article/9/6/03-0001_article.htm.

Cite This Article

DOI: 10.3201/eid1001.C11001

Table of Contents – Volume 10, Number 1—January 2004

TOP